Overview

UBS Global Healthcare Conference – May 23, 2017
ENDP Q1 2017 Slides
ENDP Q4 and Full-Year 2016 Slides
J.P. Morgan Healthcare Conference Presentation – January 9, 2017

Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.


Stock Quote
NDAQ: ENDP (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$11.84
Change (%) Stock is Up 0.19 (1.63%)
Volume6,429,244
Data as of 06/23/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
Jun 08, 2017Endo Response to June 8, 2017 FDA Meeting Related to OPANA® ERPrinter Friendly Version
Jun 07, 2017Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict LitigationPrinter Friendly Version
May 26, 2017Endo to Present at Goldman Sachs 38th Annual Global Healthcare ConferencePrinter Friendly Version
May 09, 2017Endo Reports First-Quarter 2017 Financial ResultsPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
What's New
Download Documentation 2016 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Endo International plc posts new information to the site. Just enter your e-mail address and click Submit.
 
Investor Relations Contacts:
Stephen Mock
Senior Vice President, Investor Relations and Corporate Affairs
845-364-4833
E-mail: mock.stephen@endo.com

Nina Goworek
Senior Director, Investor Relations
484-216-6657
E-mail: goworek.nina@endo.com

Heather Zoumas Lubeski
Senior Director, Corporate Affairs
484-216-6829
E-mail: zoumaslubeski.heather@endo.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet